Vimarsana
Biggest News Aggregation in the World

Page 2 - Peter Griffith News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Peter Griffith. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Peter Griffith Today - Breaking & Trending Today

Amgen Inc. (NASDAQ:AMGN) Q4 2023 Earnings Call Transcript - Vimarsana News

Amgen Inc. (NASDAQ:AMGN) Q4 2023 Earnings Call Transcript

Amgen Inc. beats earnings expectations. Reported EPS is $4.71, expectations were $4.66.

GLP-1s: 'We're investing behind this in a big way,' says Amgen CFO - Vimarsana News

GLP-1s: 'We're investing behind this in a big way,' says Amgen CFO

Amgen is focused on price declines while it looks to fill out its portfolio and chase the new obesity market.

Source: yahoo.com
Related Topics:
Peter GriffithLiver Disease
Amgen quarterly profit rises 15% as Horizon deal boosts results - Vimarsana News

Amgen quarterly profit rises 15% as Horizon deal boosts results

Amgen on Tuesday said its adjusted fourth-quarter profit rose 15%, driven by a 20% increase in revenue following the biotechnology company's October acquisition of rare disease drugmaker...

Amgen quarterly profit rises 15% as Horizon deal boosts results - Vimarsana News

Amgen quarterly profit rises 15% as Horizon deal boosts results

(Reuters) -Amgen on Tuesday said its adjusted fourth-quarter profit rose 15%, driven by a 20% increase in revenue following the biotechnology company's October acquisition of rare disease drugmaker Horizon Therapeutics. For full-year 2024, the company said it expects adjusted earnings per share of $18.90 to $20.30 on revenue of $32.4 billion to $33.8 billion. "The guidance looks good and in line with consensus," Jefferies analyst Michael Yee said in an email.

Source: yahoo.com
Amgen quarterly profit rises 15% as Horizon deal boosts results - Vimarsana News

Amgen quarterly profit rises 15% as Horizon deal boosts results

(Reuters) -Amgen on Tuesday said its adjusted fourth-quarter profit rose 15%, driven by a 20% increase in revenue following the biotechnology company's October acquisition of rare disease drugmaker Horizon Therapeutics. For full-year 2024, the company said it expects adjusted earnings per share of $18.90 to $20.30 on revenue of $32.4 billion to $33.8 billion. "The guidance looks good and in line with consensus," Jefferies analyst Michael Yee said in an email.

Source: yahoo.com